Allspring Global Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.2M Sell
71,538
-105,474
-60% -$13.2M 0.02% 713
2025
Q4
$21.5M Sell
177,012
-65,126
-27% -$7.47M 0.03% 515
2025
Q3
$24.3M Buy
242,138
+108,072
+81% +$9.73M 0.04% 496
2025
Q2
$11.1M Sell
134,066
-7,535
-5% -$601K 0.02% 677
2025
Q1
$11.5M Sell
141,601
-12,717
-8% -$1.14M 0.02% 670
2024
Q4
$13.9M Sell
154,318
-9,142
-6% -$886K 0.02% 649
2024
Q3
$16.1M Sell
163,460
-9,365
-5% -$920K 0.03% 624
2024
Q2
$16M Sell
172,825
-10,202
-6% -$915K 0.03% 623
2024
Q1
$17.4M Sell
183,027
-18,785
-9% -$1.74M 0.03% 595
2023
Q4
$18M Buy
201,812
+20,734
+11% +$1.54M 0.03% 586
2023
Q3
$13.2M Sell
181,078
-25,177
-12% -$2.01M 0.02% 667
2023
Q2
$17.2M Buy
206,255
+1,167
+0.6% +$97.6K 0.03% 641
2023
Q1
$15.6M Sell
205,088
-8,430
-4% -$699K 0.03% 668
2022
Q4
$17.7M Buy
213,518
+8,363
+4% +$677K 0.03% 619
2022
Q3
$16.3M Sell
205,155
-4,306
-2% -$363K 0.03% 615
2022
Q2
$15.6M Buy
209,461
+34,568
+20% +$2.59M 0.03% 661
2022
Q1
$15.7M Sell
174,893
-3,958
-2% -$366K 0.02% 743
2021
Q4
$20M Buy
+178,851
New +$21.6M 0.02% 704

Other funds holding XBI

Allspring Global Investments's XBI Position: Q1 2026 in Review

Allspring Global Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 60% in Q1 2026, selling an estimated $13.2M and leaving 71,538 shares worth $9.2M. The position accounts for 0.02% of the portfolio, ranked #713.

Allspring Global Investments first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $24.3M in Q3 2025. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Allspring Global Investments held 71,538 shares of State Street SPDR S&P Biotech ETF worth $9.2M as of Q1 2026.
  • Allspring Global Investments sold 105,474 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $13.2M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Allspring Global Investments's portfolio in Q1 2026, its #713 holding.
  • Allspring Global Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's State Street SPDR S&P Biotech ETF position peaked at $24.3M in Q3 2025.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.